메뉴 건너뛰기




Volumn 146, Issue , 2005, Pages 73-86

Monitoring of immunosuppressive therapy in renal transplanted patients

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

EID: 16544370677     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review
Times cited : (5)

References (53)
  • 1
    • 0035722519 scopus 로고    scopus 로고
    • Maintenance immunosuppression in the renal transplant recipient: An overview
    • Gaston R: Maintenance immunosuppression in the renal transplant recipient: An overview. Am J Kidney Dis 2001;38(suppl 6):S25-S35.
    • (2001) Am J Kidney Dis , vol.38 , Issue.6 SUPPL.
    • Gaston, R.1
  • 2
    • 0036802558 scopus 로고    scopus 로고
    • Universal approach to pharmacokinetics monitoring of immunosuppressive agents in children
    • Filler G, Feber J, Lepage N, Weiler G, Mai I: Universal approach to pharmacokinetics monitoring of immunosuppressive agents in children. Pediatr Transplant 2002;6:411-418.
    • (2002) Pediatr Transplant , vol.6 , pp. 411-418
    • Filler, G.1    Feber, J.2    Lepage, N.3    Weiler, G.4    Mai, I.5
  • 3
    • 0034897144 scopus 로고    scopus 로고
    • Current issues in therapeutic drug monitoring of mycophenolate acid: Report of a round table discussion
    • Shaw L, Holt D, Oellerich M, Meiser B, van Gelder T: Current issues in therapeutic drug monitoring of mycophenolate acid: Report of a round table discussion. Ther Drug Monit 2001;23:305-315.
    • (2001) Ther Drug Monit , vol.23 , pp. 305-315
    • Shaw, L.1    Holt, D.2    Oellerich, M.3    Meiser, B.4    Van Gelder, T.5
  • 4
    • 0030717563 scopus 로고    scopus 로고
    • Prediction of cyclosporine area under the curve using a three point sampling strategy after Neoral administration
    • Gaspari F, Anedda MF, Signorini G, Remuzzi G, Perico N: Prediction of cyclosporine area under the curve using a three point sampling strategy after Neoral administration. J Am Soc Nephrol 1997;8:647-652.
    • (1997) J Am Soc Nephrol , vol.8 , pp. 647-652
    • Gaspari, F.1    Anedda, M.F.2    Signorini, G.3    Remuzzi, G.4    Perico, N.5
  • 5
    • 0032716908 scopus 로고    scopus 로고
    • Current opinions on therapeutic drug monitoring of immunosuppressive drugs
    • Shaw L, Holt D, Keown P, Venkataramanan R, Yascoff R: Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther 1999;21:1632-1652.
    • (1999) Clin Ther , vol.21 , pp. 1632-1652
    • Shaw, L.1    Holt, D.2    Keown, P.3    Venkataramanan, R.4    Yascoff, R.5
  • 6
    • 0028079609 scopus 로고
    • Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a cross-over comparison with the market formulation
    • Mueller EA, Kovarik JM, van Bree JB, Tetzloff W, Grevel J, Kutz K: Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a cross-over comparison with the market formulation. Pharm Res 1994;11:151-155.
    • (1994) Pharm Res , vol.11 , pp. 151-155
    • Mueller, E.A.1    Kovarik, J.M.2    Van Bree, J.B.3    Tetzloff, W.4    Grevel, J.5    Kutz, K.6
  • 7
    • 0028952478 scopus 로고
    • Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals
    • Kahan BD, Dunn J, Fitts C, van Buren D, Wombold D, Pollack R, Carson R, Alexander JW, Choc M, Wong R: Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995;59:505-511.
    • (1995) Transplantation , vol.59 , pp. 505-511
    • Kahan, B.D.1    Dunn, J.2    Fitts, C.3    Van Buren, D.4    Wombold, D.5    Pollack, R.6    Carson, R.7    Alexander, J.W.8    Choc, M.9    Wong, R.10
  • 8
    • 0034192312 scopus 로고    scopus 로고
    • Pharmacokinetics validation of Neoral absorption profiling
    • Johnston A, David OJ, Cooney GF: Pharmacokinetics validation of Neoral absorption profiling. Transplant Proc 2000;32:S53-S56.
    • (2000) Transplant Proc , vol.32
    • Johnston, A.1    David, O.J.2    Cooney, G.F.3
  • 9
    • 0032846279 scopus 로고    scopus 로고
    • Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect
    • Steiner CM, Murray JJ, Wood AJ: Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect. Clin Chem 1999;45:1477-1484.
    • (1999) Clin Chem , vol.45 , pp. 1477-1484
    • Steiner, C.M.1    Murray, J.J.2    Wood, A.J.3
  • 10
    • 0033565808 scopus 로고    scopus 로고
    • Neoral monitoring by simplified sparse sampling area under the concentration-tune curve
    • Mahalati K, Belitsky P, Sketris I, West K, Panek R: Neoral monitoring by simplified sparse sampling area under the concentration-tune curve. Transplantation 1999;68:55-62.
    • (1999) Transplantation , vol.68 , pp. 55-62
    • Mahalati, K.1    Belitsky, P.2    Sketris, I.3    West, K.4    Panek, R.5
  • 11
    • 0036785209 scopus 로고    scopus 로고
    • Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts
    • Pescovitz MD, Barbeito R, Simulect US01 Study Group: Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transplant 2002;16:378-382.
    • (2002) Clin Transplant , vol.16 , pp. 378-382
    • Pescovitz, M.D.1    Barbeito, R.2
  • 12
    • 0035960050 scopus 로고    scopus 로고
    • Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation
    • Canadian Neoral Renal Transplantation Study Group: Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation. Transplantation 2001;72:1024-1032.
    • (2001) Transplantation , vol.72 , pp. 1024-1032
  • 13
    • 0003266030 scopus 로고    scopus 로고
    • Monitoring of 2-hour Neoral absorption in renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period
    • Washington DC, Apr 26-May 1
    • Pfeffer P, Stefoni S, Agost Carreno C, Thervet E, Fornarion S, Keown P, MO2ART Study Group: Monitoring of 2-hour Neoral absorption In renal transplantation (MO2ART): Interim analysis shows low incidence of acute rejection in the early post-graft period. Abstract 1037 Am Soc Transpl Congress, Washington DC, Apr 26-May 1, 2002.
    • (2002) Abstract 1037 Am Soc Transpl Congress
    • Pfeffer, P.1    Stefoni, S.2    Agost Carreno, C.3    Thervet, E.4    Fornarion, S.5    Keown, P.6
  • 14
    • 0035670894 scopus 로고    scopus 로고
    • C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
    • Citterio F, Scata MC, Borzi MT, Pozzetto U, Castagneto M: C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients. Transplant Proc 2001;33:3133-3136.
    • (2001) Transplant Proc , vol.33 , pp. 3133-3136
    • Citterio, F.1    Scata, M.C.2    Borzi, M.T.3    Pozzetto, U.4    Castagneto, M.5
  • 15
    • 0037093506 scopus 로고    scopus 로고
    • Clinical validation studies of Neoral C2 monitoring: A review
    • Nashan B, Cole E, Levy G, Thervet E: Clinical validation studies of Neoral C2 monitoring: A review. Transplantation 2002;73(suppl):S3-S11.
    • (2002) Transplantation , vol.73 , Issue.SUPPL.
    • Nashan, B.1    Cole, E.2    Levy, G.3    Thervet, E.4
  • 16
    • 0037093525 scopus 로고    scopus 로고
    • Patient management by Neoral C2 monitoring: An international consensus statement
    • Levy G, Thervet E, Lake J, Uchida K, on behalf of the CONCERT Group: Patient management by Neoral C2 monitoring: An international consensus statement. Transplantation 2002;73(suppl 9):S12-S18.
    • (2002) Transplantation , vol.73 , Issue.9 SUPPL.
    • Levy, G.1    Thervet, E.2    Lake, J.3    Uchida, K.4
  • 17
    • 0006198155 scopus 로고    scopus 로고
    • Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
    • Kahan BD, Keown P, Levy GA, Johnston A: Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 2000;24:1-21.
    • (2000) Clin Ther , vol.24 , pp. 1-21
    • Kahan, B.D.1    Keown, P.2    Levy, G.A.3    Johnston, A.4
  • 19
    • 0038684549 scopus 로고    scopus 로고
    • Pharmacokinetics of Tacrolimus-based therapies
    • Undre NA: Pharmacokinetics of Tacrolimus-based therapies. Nephrol Dial Transplant 2003;18(suppl 1):i12-i15.
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.1 SUPPL.
    • Undre, N.A.1
  • 20
    • 0029849460 scopus 로고    scopus 로고
    • Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation
    • Kershner RP, Fitzsimmons WE: Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 1996;62:920-926.
    • (1996) Transplantation , vol.62 , pp. 920-926
    • Kershner, R.P.1    Fitzsimmons, W.E.2
  • 23
    • 0032704588 scopus 로고    scopus 로고
    • Pharmacokinetics of Tacrolimus: Clinically relevant aspects
    • Undre NA, Stevenson P, Schafer A: Pharmacokinetics of Tacrolimus: Clinically relevant aspects. Transplant Proc 1999:31(suppl 7):S21-S24.
    • (1999) Transplant Proc , vol.31 , Issue.7 SUPPL.
    • Undre, N.A.1    Stevenson, P.2    Schafer, A.3
  • 24
    • 0035993643 scopus 로고    scopus 로고
    • Effect of bile flow on the absorption of Tacrolimus in liver allograft transplantation
    • Bottiger Y, Undre NA, Sawe J, Stevenson PJ, Ericzon BG: Effect of bile flow on the absorption of Tacrolimus in liver allograft transplantation. Transplant Proc 2002;34:1544-1545.
    • (2002) Transplant Proc , vol.34 , pp. 1544-1545
    • Bottiger, Y.1    Undre, N.A.2    Sawe, J.3    Stevenson, P.J.4    Ericzon, B.G.5
  • 25
    • 0029917782 scopus 로고    scopus 로고
    • Pharmacokinetics of mycophenolate mofetil (RS61443): A short review
    • Bullingham RES, Nicholls A, Hale M: Pharmacokinetics of mycophenolate mofetil (RS61443): A short review. Transplant Proc 1996;28:925-929.
    • (1996) Transplant Proc , vol.28 , pp. 925-929
    • Bullingham, R.E.S.1    Nicholls, A.2    Hale, M.3
  • 27
    • 0033981118 scopus 로고    scopus 로고
    • Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation
    • Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman ICL: Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000;22:14-19.
    • (2000) Ther Drug Monit , vol.22 , pp. 14-19
    • Shaw, L.M.1    Kaplan, B.2    DeNofrio, D.3    Korecka, M.4    Brayman, I.C.L.5
  • 28
    • 0029058395 scopus 로고
    • Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics
    • Nowak I, Shaw LM: Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics. Clin Chem 1995;41:1011-1017.
    • (1995) Clin Chem , vol.41 , pp. 1011-1017
    • Nowak, I.1    Shaw, L.M.2
  • 30
    • 0032128401 scopus 로고    scopus 로고
    • Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection
    • Nicholls AJ: Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/ pharmacodynamic relationship for mycophenolic acid and suppression of rejection. Clin Biochem 1998;31:329-333.
    • (1998) Clin Biochem , vol.31 , pp. 329-333
    • Nicholls, A.J.1
  • 32
    • 0033797428 scopus 로고    scopus 로고
    • Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients
    • Willis C, Taylor PJ, Salm P, Tett SE, Pillans PI: Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients. Ther Drug Monit 2000;22:549-554.
    • (2000) Ther Drug Monit , vol.22 , pp. 549-554
    • Willis, C.1    Taylor, P.J.2    Salm, P.3    Tett, S.E.4    Pillans, P.I.5
  • 33
    • 2442712496 scopus 로고    scopus 로고
    • Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is prefereable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy
    • Filler G: Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is prefereable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy. Transpl Int 2004;17:120-125.
    • (2004) Transpl Int , vol.17 , pp. 120-125
    • Filler, G.1
  • 35
    • 0042536429 scopus 로고    scopus 로고
    • Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
    • Knoll GA, Mac Donald I, Khan A, van Walraven C: Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003;14:2381-2386.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 2381-2386
    • Knoll, G.A.1    Mac Donald, I.2    Khan, A.3    Van Walraven, C.4
  • 36
    • 0033376927 scopus 로고    scopus 로고
    • Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipient
    • Kelly PA, Napoli KL, Kahan BD: Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipient. Biopharm Drug Dispos 2000;20:249-253.
    • (2000) Biopharm Drug Dispos , vol.20 , pp. 249-253
    • Kelly, P.A.1    Napoli, K.L.2    Kahan, B.D.3
  • 37
    • 0031008434 scopus 로고    scopus 로고
    • Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration
    • Zimmerman JJ, Kahan BD: Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997;37:405-415.
    • (1997) J Clin Pharmacol , vol.37 , pp. 405-415
    • Zimmerman, J.J.1    Kahan, B.D.2
  • 38
    • 0038298948 scopus 로고    scopus 로고
    • Therapeutic monitoring of sirolimus: Its contribution to optimal prescription
    • Holt DW, Denny K, Lee TD, Johnston A: Therapeutic monitoring of sirolimus: Its contribution to optimal prescription. Transplant Proc 2003;35(suppl 3):S157-S161.
    • (2003) Transplant Proc , vol.35 , Issue.3 SUPPL.
    • Holt, D.W.1    Denny, K.2    Lee, T.D.3    Johnston, A.4
  • 39
    • 2942560551 scopus 로고    scopus 로고
    • Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients
    • Oellerich M, Armstrong V, Streit F, Weber L, Tonshoff B: Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. Clin Biochem 2004;37:624-628.
    • (2004) Clin Biochem , vol.37 , pp. 624-628
    • Oellerich, M.1    Armstrong, V.2    Streit, F.3    Weber, L.4    Tonshoff, B.5
  • 41
    • 0036138190 scopus 로고    scopus 로고
    • Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction
    • Kovaric JM, Kalbag J, Figueiredo J, Rouilly M, Frazier OL, Rordorf C: Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction. J Clin Pharmacol 2002;42:95-99.
    • (2002) J Clin Pharmacol , vol.42 , pp. 95-99
    • Kovaric, J.M.1    Kalbag, J.2    Figueiredo, J.3    Rouilly, M.4    Frazier, O.L.5    Rordorf, C.6
  • 44
    • 0027994206 scopus 로고
    • FK506 metabolism in human liver microsomes: Investigation of the involvment of cytochrome P450 isoenzymes other than CYP3A4
    • Karanam BV, Vincent SH, Newton DJ, Wang RW, Chiu SH: FK506 metabolism in human liver microsomes: Investigation of the involvment of cytochrome P450 isoenzymes other than CYP3A4. Drug Metab Dispos 1994;22:811-814.
    • (1994) Drug Metab Dispos , vol.22 , pp. 811-814
    • Karanam, B.V.1    Vincent, S.H.2    Newton, D.J.3    Wang, R.W.4    Chiu, S.H.5
  • 50
    • 0034065402 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
    • MacDonald A, Scarola J, Burke JT, Zimmerman JJ: Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 2000;22(suppl B):B101-B121.
    • (2000) Clin Ther , vol.22 , Issue.SUPPL. B
    • MacDonald, A.1    Scarola, J.2    Burke, J.T.3    Zimmerman, J.J.4
  • 51
    • 0038684549 scopus 로고    scopus 로고
    • Pharmacokinetics of tacrolimus-based combination therapies
    • Undre Na: Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial transplant 2003;18(suppl 1):i12-i15.
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.1 SUPPL.
    • Na, U.1
  • 52
    • 0029817346 scopus 로고    scopus 로고
    • Toxic effects of immunosuppressive drugs: Mechanism and strategies for controlling them
    • Shaw LM, Kaplan B, Kaufman D: Toxic effects of immunosuppressive drugs: Mechanism and strategies for controlling them. Clin Chem 1996;42:1316-1321.
    • (1996) Clin Chem , vol.42 , pp. 1316-1321
    • Shaw, L.M.1    Kaplan, B.2    Kaufman, D.3
  • 53
    • 0002379569 scopus 로고    scopus 로고
    • Established immunosuppressive drugs: Clinical and toxic effects
    • Kahan B, Ponticelli C (eds): London, Martin Dunitz
    • Kahan B, Ponticelli C: Established immunosuppressive drugs: Clinical and toxic effects; in Kahan B, Ponticelli C (eds): Principles and Practice of Renal Transplantation. London, Martin Dunitz, 2000, pp 349-414.
    • (2000) Principles and Practice of Renal Transplantation , pp. 349-414
    • Kahan, B.1    Ponticelli, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.